Quantifying signaling pathway activation to monitor the quality of induced pluripotent stem cells

Oncotarget
Eugene MakarevAnthony Atala

Abstract

Many attempts have been made to evaluate the safety and potency of human induced pluripotent stem cells (iPSCs) for clinical applications using transcriptome data, but results so far have been ambiguous or even contradictory. Here, we characterized stem cells at the pathway level, rather than at the gene level as has been the focus of previous work. We meta-analyzed publically-available gene expression data sets and evaluated signaling and metabolic pathway activation profiles for 20 human embryonic stem cell (ESC) lines, 12 human iPSC lines, five embryonic body lines, and six fibroblast cell lines. We demonstrated the close resemblance of iPSCs with ESCs at the pathway level, and provided examples of how pathway activity can be applied to identify iPSC line abnormalities or to predict in vitro differentiation potential. Our results indicate that pathway activation profiling is a promising strategy for evaluating the safety and potency of iPSC lines in translational medicine applications.

References

Nov 6, 1998·Science·J A ThomsonJ M Jones
Feb 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Bao-Yang HuSu-Chun Zhang
Mar 4, 2011·Nature·Samer M HusseinTimo Otonkoski
May 5, 2011·Nature Cell Biology·Sean M Wu, Konrad Hochedlinger
Jan 31, 2013·Development·Zengrong Zhu, Danwei Huangfu
Jan 27, 2015·World Journal of Stem Cells·Tomohisa Seki, Keiichi Fukuda

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE25970

Software Mentioned

Atlas
LASSO
R
R package glmnet
MS Excel
R package gplots
Bioconductor
Regeneration Intelligence
OncoFinder

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.